- Home
- MATX vs PRCT Comparison
MATX vs PRCT Comparison
Compare MATX & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATX
- PRCT
- Stock Information
- Founded
- MATX 1882
- PRCT 2009
- Country
- MATX United States
- PRCT United States
- Employees
- MATX N/A
- PRCT N/A
- Industry
- MATX Marine Transportation
- PRCT Medical Specialities
- Sector
- MATX Consumer Discretionary
- PRCT Health Care
- Exchange
- MATX Nasdaq
- PRCT Nasdaq
- Market Cap
- MATX 4.6B
- PRCT 5.3B
- IPO Year
- MATX N/A
- PRCT 2021
- Fundamental
- Price
- MATX $142.64
- PRCT $87.09
- Analyst Decision
- MATX Buy
- PRCT Strong Buy
- Analyst Count
- MATX 4
- PRCT 7
- Target Price
- MATX $135.33
- PRCT $97.86
- AVG Volume (30 Days)
- MATX 227.1K
- PRCT 475.4K
- Earning Date
- MATX 10-30-2024
- PRCT 10-28-2024
- Dividend Yield
- MATX 0.94%
- PRCT N/A
- EPS Growth
- MATX 37.01
- PRCT N/A
- EPS
- MATX 11.85
- PRCT N/A
- Revenue
- MATX $3,320,400,000.00
- PRCT $199,843,000.00
- Revenue This Year
- MATX $11.52
- PRCT $67.07
- Revenue Next Year
- MATX N/A
- PRCT $40.64
- P/E Ratio
- MATX $12.10
- PRCT N/A
- Revenue Growth
- MATX 6.86
- PRCT 71.71
- 52 Week Low
- MATX $100.50
- PRCT $39.48
- 52 Week High
- MATX $169.12
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- MATX 39.04
- PRCT 39.61
- Support Level
- MATX $142.83
- PRCT $88.41
- Resistance Level
- MATX $146.74
- PRCT $92.92
- Average True Range (ATR)
- MATX 3.41
- PRCT 3.70
- MACD
- MATX -1.22
- PRCT -1.38
- Stochastic Oscillator
- MATX 3.79
- PRCT 0.48
About MATX Matson Inc.
Matson Inc is engaged in providing ocean transportation and logistics services. The business segments of the company are Ocean Transportation which provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific, and Logistics segment which offers long haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from Ocean Transportation segment.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.